Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Notice of Charter Renewal, 62240 [2012-25096]
Download as PDF
<![CDATA[
62240
Federal Register / Vol. 77, No. 198 / Friday, October 12, 2012 / Notices
wreier-aviles on DSK5TPTVN1PROD with NOTICES
care costs, higher quality of care, and
improved service offerings. Left
unremedied, the proposed acquisition
likely would cause anticompetitive
harm by enabling UHS to profit by
unilaterally raising the reimbursement
rates negotiated with commercial health
plans. These costs are ultimately borne
by consumers in the form of higher
premiums, co-pays, and other out-ofpocket costs. The loss of competition
also reduces UHS?s incentive to
improve quality and provide better
service.
New entry or expansion is unlikely to
deter or counteract the anticompetitive
effects of the proposed acquisition.
While regulatory barriers to opening a
new psychiatric facility or unit are
lower in Texas and New Mexico than in
other states (e.g., there are no Certificate
of Need regulations in either state), local
zoning regulations, Medicaid and
Medicare certifications, and the need to
develop strong relationships with local
patient referral sources hinder the
ability of firms to enter the market. Cuts
to Medicaid funding may also affect the
financial incentive of a provider to offer
inpatient psychiatric services. Thus, it is
unlikely that new entry or expansion
sufficient to achieve a significant market
impact will occur in a timely manner.
IV. The Proposed Consent Agreement
The proposed Consent Agreement
wholly remedies the anticompetitive
effects in the El Paso/Santa Teresa
market by requiring UHS to divest Peak,
located in Santa Teresa, New Mexico,
and its associated operations and
businesses within six months after
issuance of the Decision and Order. The
potential acquirer of Peak is subject to
prior approval of the Commission. The
Consent Agreement also provides that, if
Peak is not sold to an approved acquirer
within six months, a Divestiture Trustee
will be appointed and empowered to
divest both Peak and Mesilla Valley.
The purpose of this provision is to
address the uncertainty of whether Peak
alone is sufficient to attract an acquirer
that would compete as effectively as
UHS competed prior to the merger.
Until completion of the requisite
divestiture(s), UHS is required to abide
by the Order to Hold Separate and
Maintain Assets, which includes a
requirement that UHS hold Peak
separate from its other businesses and
facilities, and a requirement to take all
actions necessary to maintain the
economic viability, marketability, and
competitiveness of the both the Peak
and Mesilla Valley assets. The Consent
Agreement also requires UHS to provide
transitional services to the approved
acquirer for one year, as needed to assist
VerDate Mar<15>2010
13:59 Oct 11, 2012
Jkt 229001
the acquirer with operating the divested
assets as a viable and ongoing business.
In addition, the proposed order allows
the Commission to appoint a Hold
Separate Trustee to oversee UHS’s
compliance with the Order to Hold
Separate and Maintain Assets. Finally,
the proposed order contains a ten-year
prior notice requirement for acquisitions
of acute inpatient psychiatric service
providers in the local area, as well as
compliance reporting requirements.
The sole purpose of this analysis is to
facilitate public comment on the
Consent Agreement. This analysis does
not constitute an official interpretation
of the Consent Agreement or modify its
terms in any way.
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. 2012–25140 Filed 10–11–12; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Notice of Charter
Renewal
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel, Centers
for Disease Control and Prevention,
Department of Health and Human
Services, has been renewed for a 2-year
period through September 18, 2014.
For information, contact John
Kastenbauer, J.D., Designated Federal
Officer, Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel, Centers for Disease
Control and Prevention, Department of
Health and Human Services, 1600
Clifton Road NE., Mailstop E11, Atlanta,
Georgia 30333, telephone (770)488–
4778 or fax (770)488–4890.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
Dated: October 5, 2012.
John Kastenbauer,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2012–25096 Filed 10–11–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention announces the
following meeting of the
aforementioned committee:
Time and Date: 11:00 a.m.–3:00 p.m.,
November 5, 2012.
Place: Audio Conference Call via FTS
Conferencing. The USA toll-free, dial-in
number is 1–866–659–0537 and the pass
code is 9933701.
Status: Open to the public, but
without a verbal public comment
period. Written comment should be
provided to the contact person below in
advance of the meeting.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines,
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to the CDC.
NIOSH implements this responsibility
for CDC. The charter was issued on
August 3, 2001, renewed at appropriate
E:\FR\FM\12OCN1.SGM
12OCN1
]]>Agencies
[Federal Register Volume 77, Number 198 (Friday, October 12, 2012)]
[Notices]
[Page 62240]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-25096]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel: Notice of Charter Renewal
This gives notice under the Federal Advisory Committee Act (Pub. L.
92-463) of October 6, 1972, that Disease, Disability, and Injury
Prevention and Control Special Emphasis Panel, Centers for Disease
Control and Prevention, Department of Health and Human Services, has
been renewed for a 2-year period through September 18, 2014.
For information, contact John Kastenbauer, J.D., Designated Federal
Officer, Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel, Centers for Disease Control and Prevention, Department
of Health and Human Services, 1600 Clifton Road NE., Mailstop E11,
Atlanta, Georgia 30333, telephone (770)488-4778 or fax (770)488-4890.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Dated: October 5, 2012.
John Kastenbauer,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2012-25096 Filed 10-11-12; 8:45 am]
BILLING CODE 4163-18-P
